Depression for a tablet
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of a depression for a tablet showing our new design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a front elevational view thereof, the rear elevational view is identical; and,
FIG. 4 is a right side elevational view thereof, the left side elevational view is identical.
The broken line drawing of a tablet in all figure views is for illustrative purposes only and forms no part of the claimed design.
Referenced Cited
U.S. Patent Documents
Other references
| D258091 | January 27, 1981 | Reed et al. |
| D285490 | September 2, 1986 | Tovey |
| D286086 | October 7, 1986 | Tovey |
| D301637 | June 13, 1989 | Tovey |
| D309035 | July 3, 1990 | Ni et al. |
| D312322 | November 20, 1990 | Calandrillo |
- Physicians' Desk Reference, Permax (p. 415) and Nolvadex (p. 412), 44th Ed., 1990.
Patent History
Patent number: D377977
Type: Grant
Filed: Jul 9, 1994
Date of Patent: Feb 11, 1997
Assignee: Glaxo Group Limited (Middlesex)
Inventors: Philip T. Price (Ware), Michael B. Davies (Ware), Paul K. Rand (Letchworth), Yogendra Dandiker (Ware), Colin R. Heppenstall (Bishop's Stortford), Paul D. Huckle (Royston)
Primary Examiner: M. H. Tung
Law Firm: Bacon & Thomas
Application Number: 0/25,203
Type: Grant
Filed: Jul 9, 1994
Date of Patent: Feb 11, 1997
Assignee: Glaxo Group Limited (Middlesex)
Inventors: Philip T. Price (Ware), Michael B. Davies (Ware), Paul K. Rand (Letchworth), Yogendra Dandiker (Ware), Colin R. Heppenstall (Bishop's Stortford), Paul D. Huckle (Royston)
Primary Examiner: M. H. Tung
Law Firm: Bacon & Thomas
Application Number: 0/25,203
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)
